Cat.#: ACPP-1186
| Despition | Olig2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1370 | EFEMP1 Blocking Peptide (AC1370) | 250 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
| ACPP-1128 | Recombinant Human Vimentin Protein (AC1128) | 25 µl | inquiry |
| ACPP-1365 | Progesterone Receptor Blocking Peptide (AC1365) | 250 µg | inquiry |
| ACPP-1766 | Human HMGA2 Protein (AC1766) | 2 µg | inquiry |
| ACPP-1638 | Human CNTF Protein (AC1638) | 5 µg | inquiry |
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.